Table 1.
Patient characteristics at index date
| Pediatric mild-to-moderate cohort | Pediatric severe cohort | Reference cohort | |
|---|---|---|---|
| Number of unique patients | 87,721 | 11,609 | 87,721 |
| Age group | |||
| 0–4 | 59,192 (67.5%) | 6556 (56.5%) | 59,192 (67.5%) |
| 5–9 | 17,469 (19.9%) | 2836 (24.4%) | 17,469 (19.9%) |
| 10–14 | 11,060 (12.6%) | 2217 (19.1%) | 11,060 (12.6%) |
| Gender | |||
| Female | 41,036 (46.8%) | 4922 (42.4%) | 41,036 (46.8%) |
| Male | 46,685 (53.2%) | 6687 (57.6%) | 46,685 (53.2%) |
| Treatment type at index datea | |||
| TCSb | 78,122 (89.1%) | 10,416 (89.7%) | |
| TCIc | 1758 (2.0%) | 318 (2.7%) | |
| No treatmentd | 9056 (10.3%) | 1106 (9.5%) | |
aNumber of patients may exceed number of unique patients since one patient may use TCS and TCI concomitantly
bTopical corticosteroid
cTopical calcineurin inhibitor
dPatients were followed from first diagnosis in secondary care